<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>USP5 &#8211; openlabnotebooks.org</title>
	<atom:link href="https://thesgc.github.io/static-openlabnotebooks/category/project/usp5/feed/" rel="self" type="application/rss+xml" />
	<link>https://thesgc.github.io/static-openlabnotebooks/</link>
	<description>A growing team of groundbreaking scientists around the world are now sharing their lab notebooks online</description>
	<lastBuildDate>Thu, 05 Nov 2020 17:07:48 +0000</lastBuildDate>
	<language>en-GB</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=5.5.3</generator>

<image>
	<url>https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/01/cropped-lab-jar02-32x32.png</url>
	<title>USP5 &#8211; openlabnotebooks.org</title>
	<link>https://thesgc.github.io/static-openlabnotebooks/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Development and Optimization of an IQF USP5 Activity Assay</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/development-and-optimization-of-an-iqf-usp5-activity-assay/</link>
					<comments>https://thesgc.github.io/static-openlabnotebooks/development-and-optimization-of-an-iqf-usp5-activity-assay/#respond</comments>
		
		<dc:creator><![CDATA[Mandeep Mann]]></dc:creator>
		<pubDate>Thu, 05 Nov 2020 16:58:16 +0000</pubDate>
				<category><![CDATA[Mandeep Mann]]></category>
		<category><![CDATA[SGC Univ. of Toronto]]></category>
		<category><![CDATA[USP5]]></category>
		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=5335</guid>

					<description><![CDATA[In a previous post, I described a ubiquitin-rhodamine110 (UbRho110) assay, and showed that a ZnF-UBD ligand antagonizes USP5 catalytic activity. UbRho110 is not a native substrate, and validation with native polyubiquitin species in an orthogonal assay is required. To address this, I developed and optimized an internally quenched fluorophore pair (IQF) assay. You can see <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/development-and-optimization-of-an-iqf-usp5-activity-assay/">Read More ...</a>]]></description>
										<content:encoded><![CDATA[<p>In a <a href="https://thesgc.github.io/static-openlabnotebooks/usp5-ubiquitin-rhodamine110-catalytic-activity-assay/">previous post</a>, I described a ubiquitin-rhodamine110 (UbRho110) assay, and showed that a ZnF-UBD ligand antagonizes USP5 catalytic activity. UbRho110 is not a native substrate, and validation with native polyubiquitin species in an orthogonal assay is required. To address this, I developed and optimized an internally quenched fluorophore pair (IQF) assay. You can see details on <strong><a href="https://zenodo.org/record/4247576#.X6QridBKg2w">Zenodo. </a></strong></p>
<p>The IQF assay uses di-ubiquitin substrates, one of which carries a fluorophore that is silenced by a nearby quencher. After the di-ubiquitin substrate is cleaved by a deubiquitinase (DUB) such as USP5, the free fluorophore can be detected through a fluorescence signal (Figure 1).</p>
<p style="text-align: center;"><img loading="lazy" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/11/20201105_fig1-300x146.jpg" alt="" width="335" height="163" class=" wp-image-5336 aligncenter" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/11/20201105_fig1-300x146.jpg 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/11/20201105_fig1.jpg 624w" sizes="(max-width: 335px) 100vw, 335px" /><strong>Figure 1</strong>. Summary of IQF assay. Image taken from <a href="https://lifesensors.com/iqf/">LifeSensors</a>.</p>
<p>I tested two di-ubiquitin IQF substrates: Ub2K63 and Ub2K48. A ZnF-UBD ligand, <a href="https://thesgc.github.io/static-openlabnotebooks/expansion-of-ubtr012574-chemical-series/">UBTR020994a</a> (K<sub>D</sub>= 8 ± 2 µM [n=3]) equipotently antagonizes USP5 DUB activity for both diubiquitin substrates in a dose-dependent manner (Figure 2).</p>
<p style="text-align: center;"><strong>a)</strong><img loading="lazy" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/11/20201105_fig2a-300x96.png" alt="" width="178" height="57" class="wp-image-5337 aligncenter" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/11/20201105_fig2a-300x96.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/11/20201105_fig2a.png 638w" sizes="(max-width: 178px) 100vw, 178px" /></p>
<p style="text-align: center;"><strong>b) </strong></p>
<p style="text-align: center;"><img loading="lazy" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/11/20201105_fig2b-300x159.png" alt="" width="230" height="122" class="alignnone wp-image-5338" style="font-size: 1.5rem;" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/11/20201105_fig2b-300x159.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/11/20201105_fig2b.png 649w" sizes="(max-width: 230px) 100vw, 230px" /></p>
<p style="text-align: center;"><strong>c)</strong><img loading="lazy" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/11/20201105_fig2c-300x214.png" alt="" width="233" height="166" class=" wp-image-5339 aligncenter" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/11/20201105_fig2c-300x214.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/11/20201105_fig2c.png 577w" sizes="(max-width: 233px) 100vw, 233px" /></p>
<p style="text-align: center;"><strong>Figure 2</strong>. a) Chemical structure of UBTR020994a (K<sub>D</sub>= 8 ± 2 µM [n=3]) b) Dose-response of UBTR020994a and Ub2K63 (n=3)  IC50  ̴ 63 µM c) Dose-response of UBTR020994a and Ub2K48 (n=3) IC50=45 ± 17 µM</p>
<p>In addition to the wild-type (WT) USP5, I tested a R221A and C335S mutant. The R221A is a ZnF-UBD mutant, where R221 co-ordinates ubiquitin binding at the ZnF-UBD. C335S is a mutant of the catalytic cysteine and prevents the cleavage of the isopeptide bond in ubiquitin chains. The R221A mutant has little to no activity with Ub2K48 substrate-comparable to inhibition of the WT-USP5 with a ZnF-UBD antagonist, UBTR020994a. IQF Ub2K63 has approximately 50% activity for R221A mutant, suggesting R221 may be more important for recruitment and placement of Ub2K48 substrate than Ub2K63 substrate.  C335S is inactive in the assay.</p>
<p><img loading="lazy" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/11/20201105_fig3d.png" alt="" width="99" height="30" class=" wp-image-5340 aligncenter" /><img loading="lazy" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/11/20201105_fig2a-300x96.png" alt="" width="113" height="36" class="wp-image-5337 aligncenter" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/11/20201105_fig2a-300x96.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/11/20201105_fig2a.png 638w" sizes="(max-width: 113px) 100vw, 113px" /></p>
<p><strong>a)</strong>                                                        <strong>  b)</strong></p>
<p><img loading="lazy" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/11/20201105_fig3a-300x290.png" alt="" width="226" height="218" class="alignnone wp-image-5341" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/11/20201105_fig3a-300x290.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/11/20201105_fig3a.png 433w" sizes="(max-width: 226px) 100vw, 226px" /><img loading="lazy" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/11/20201105_fig3b-300x269.png" alt="" width="242" height="217" class="alignnone wp-image-5342" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/11/20201105_fig3b-300x269.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/11/20201105_fig3b.png 477w" sizes="(max-width: 242px) 100vw, 242px" /></p>
<p style="text-align: center;"><strong>Figure 3</strong>. USP5 DUB Activity for wild-type (WT) USP5, a ZnF-UBD mutant (R221A), a catalytic mutant (C335S) ± 2 mM UBTR020994a: a) Ub2K63 (N=2) b) Ub2K48 (N=3)</p>
<p>In the future, I will be repeating experiments with the USP5 mutants and dose-response curves for UBTR020994a for both IQF substrates to confirm the results. I also hope to test other lysine-linked di-ubiquitin substrates, such as K11, using this IQF assay.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/development-and-optimization-of-an-iqf-usp5-activity-assay/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Expansion of UBTR012574 Chemical Series Pt. II</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/expansion-of-ubtr012574-chemical-series-pt-ii/</link>
					<comments>https://thesgc.github.io/static-openlabnotebooks/expansion-of-ubtr012574-chemical-series-pt-ii/#respond</comments>
		
		<dc:creator><![CDATA[Mandeep Mann]]></dc:creator>
		<pubDate>Thu, 09 Apr 2020 18:32:05 +0000</pubDate>
				<category><![CDATA[Mandeep Mann]]></category>
		<category><![CDATA[SGC Univ. of Toronto]]></category>
		<category><![CDATA[USP5]]></category>
		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=4481</guid>

					<description><![CDATA[Structure Image Smiles Mol. Weight Cc1cc(C(=O)NCC(=O)O)ccc1S(=O)(=O)N1CCC(N2CCCC2)CC1 409.5 In a previous post, I showed the expansion of UBTR012574 chemical series from commercial sources- Enamine’s REAL database and Scifinder to shed some insight into the structural activity relationship (SAR) (Figure 1). Figure 1. UBTR012574 chemical series UBTR020988a which has an amide resulted in weaker potency for USP5 <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/expansion-of-ubtr012574-chemical-series-pt-ii/">Read More ...</a>]]></description>
										<content:encoded><![CDATA[<table data-upload-id="file_upload:b80ae1b4-d17f-405e-8c18-73dea3819a92" style="display: none;">
<thead>
<tr>
<th>Structure Image</th>
<th>Smiles</th>
<th>Mol. Weight</th>
</tr>
</thead>
<tbody>
<tr>
<td><img src="data:image/png;base64,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" /></td>
<td>Cc1cc(C(=O)NCC(=O)O)ccc1S(=O)(=O)N1CCC(N2CCCC2)CC1</td>
<td>409.5</td>
</tr>
</tbody>
</table>
<p><span style="font-size: 1.5rem;">In a </span><a style="font-size: 1.5rem;" href="https://thesgc.github.io/static-openlabnotebooks/expansion-of-ubtr012574-chemical-series/">previous post</a><span style="font-size: 1.5rem;">, I showed the expansion of UBTR012574 chemical series from commercial sources- Enamine’s REAL database and Scifinder to shed some insight into the structural activity relationship (SAR) (Figure 1).</span></p>
<p><img loading="lazy" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/04/20200409b-300x245.png" alt="" width="371" height="303" class="wp-image-4483 aligncenter" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/04/20200409b-300x245.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/04/20200409b.png 396w" sizes="(max-width: 371px) 100vw, 371px" /></p>
<p style="text-align: center;"><strong>Figure 1</strong>. UBTR012574 chemical series</p>
<p>UBTR020988a which has an amide resulted in weaker potency for USP5 but is 6-fold selective for USP5 over HDAC6. Keeping the SAR in mind, we hope to improve potency and retain selectivity for USP5 ZnF-UBD. After exhausting commercial sources of compounds against USP5 ZnF-UBD, we started a collaboration with chemists at the Ontario Institute for Cancer Research (OICR) to continue to expand the UBTR012574 chemical series.</p>
<p>I docked 124 analogues of UBTR012574 generated by Dr. Carlos Zepeda and Hector Gonzaled-Alvarez at OICR based on ease of synthesis and available starting materials to USP5 ZnF-UBD to help prioritize synthesis. All docked analogues are amides, to retain selectivity based on SAR (UBTR20988) as well as easier chemistry. You can find details on <a href="https://zenodo.org/record/3746518#.Xo9na4hKjIU"><strong>Zenodo</strong></a><strong>.</strong></p>
<p>Of the docked analogues, there were two docking poses where (1) an aromatic ring makes pi-stacking interactions with Y223 (Figure 2- cyan) or (2) an ammonium group forms an H-bond with D264 (Figure 2-green).</p>
<p><img loading="lazy" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/04/20200409a-300x148.png" alt="" width="503" height="248" class="wp-image-4482 aligncenter" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/04/20200409a-300x148.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/04/20200409a-768x378.png 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/04/20200409a.png 925w" sizes="(max-width: 503px) 100vw, 503px" /></p>
<p style="text-align: center;"><strong>Figure 2.</strong> USP5 ZnF-UBD co-crystal structure with UBTR012574 (magenta) and docked poses of analogues (cyan &amp; green)</p>
<p>This data was shared with chemists to be used to prioritize the synthesis of the first subset of analogues. The compounds with the best docking scores and poses will be synthesized in the first instance. Starting materials have been ordered; however, synthesis has been put on hold for COVID-19 related lab closures. Once labs re-open, we hope to get started on synthesizing and testing some of these compounds. Stay tuned!</p>
<p><a href="/wp-content/uploads/2020/04/4481_e5233d6f-d811-4ca8-be31-4a2451b572de.sdf">Download SDF file</a></p>
<p><a href="/wp-content/uploads/2020/04/4481_fd106e61-ce7d-4c52-bc24-1cb19ded9022.sdf">Download SDF file</a></p>
]]></content:encoded>
					
					<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/expansion-of-ubtr012574-chemical-series-pt-ii/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>USP5 and ubiquitin interaction assay &#8211; NaNoBRET</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/usp5-and-ubiquitin-interaction-assay-nanobret/</link>
					<comments>https://thesgc.github.io/static-openlabnotebooks/usp5-and-ubiquitin-interaction-assay-nanobret/#respond</comments>
		
		<dc:creator><![CDATA[Magdalena Szewczyk]]></dc:creator>
		<pubDate>Thu, 26 Mar 2020 14:24:36 +0000</pubDate>
				<category><![CDATA[Cell assay reports]]></category>
		<category><![CDATA[Magdalena Szewczyk]]></category>
		<category><![CDATA[SGC Univ. of Toronto]]></category>
		<category><![CDATA[USP5]]></category>
		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=4389</guid>

					<description><![CDATA[Hi Here are the details of the assay I developed to measure interaction between USP5 and ubiquitin in cells. Ubiquitin specific peptidase 5 (USP5) belongs to the largest ubiquitin-specific protease (USP) subfamily and has a zinc finger at its N-terminal portion and two ubiquitin-associated domains in the large catalytic region that mediate polyubiquitin binding (PMID:28923280, <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/usp5-and-ubiquitin-interaction-assay-nanobret/">Read More ...</a>]]></description>
										<content:encoded><![CDATA[<p>Hi</p>
<p>Here are the details of the assay I developed to measure interaction between USP5 and ubiquitin in cells.</p>
<p>Ubiquitin specific peptidase 5 (USP5) belongs to the largest ubiquitin-specific protease (USP) subfamily and has a zinc finger at its N-terminal portion and two ubiquitin-associated domains in the large catalytic region that mediate polyubiquitin binding (PMID:28923280, PMID:18482987). Structural and biochemical analysis indicated that USP5 cleaved preferentially branched ubiquitins, including unanchored polyubiquitin chains (PMID:19098288). The zinc finger ubiquitin-binding domain (Zf-UBD) recognizes the proximal C-terminal di-glycine motif of ubiquitin (Fig.1).</p>
<p><img loading="lazy" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/03/AllHandsStaffMeetingslides-300x124.png" alt="" class="alignnone wp-image-4393" width="692" height="286" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/03/AllHandsStaffMeetingslides-300x124.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/03/AllHandsStaffMeetingslides-1024x424.png 1024w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/03/AllHandsStaffMeetingslides-768x318.png 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/03/AllHandsStaffMeetingslides.png 1267w" sizes="(max-width: 692px) 100vw, 692px" /></p>
<p><strong>Fig.1. The Zf-UBD recognizes the proximal C-terminal di-glycine motif of ubiquitin. </strong>Crystal structure of ubiquitin (blue) binding to USP5 zinc finger ubiquitin-binding domain (grey). Data generated by <strong>Mandeep Mann</strong>.</p>
<p>Assay measuring the interaction of USP5 to ubiquitin was developed using NanoBRET technology &#8211; a proximity-based assay that can detect protein interactions by measuring energy transfer from a bioluminescent protein donor to a fluorescent protein acceptor. We tested different amounts of the donor (N-terminally or C-terminally NanoLuc® tagged full-length USP5) and acceptor (N-terminally HaloTag®Fusion-tagged wild type ubiquitin and mutant lacking RGG motif) constructs in two different cell lines (MCF7 and HEK293). Consistently with <em>in vitro </em>data ubiquitin lacking the last three C-terminal RGG showed lower interaction compared to wild type ubiquitin (Fig.2). The best WT to Mutant ratio was observed in MCF7 transfected with 0.02 µg of HaloTag®Fusion-tagged -Ub/UbdelRGG and 0.001 µg of N- terminally NanoLuc® -tagged-USP5 per 96-well (Fig.2A).</p>
<p><strong>Please see the experimental details on <a href="https://zenodo.org/record/3727689#.XnzUqYhKg2x">Zenodo</a>.</strong></p>
<p>&nbsp;</p>
<p><img loading="lazy" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/03/usp5-1-300x200.png" alt="" class="alignnone wp-image-4391" style="font-size: 1.5rem;" width="725" height="483" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/03/usp5-1-300x200.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/03/usp5-1-768x513.png 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/03/usp5-1.png 952w" sizes="(max-width: 725px) 100vw, 725px" /></p>
<p>&nbsp;</p>
<p><strong>Fig.2. USP5 interaction with ubiquitin and delRGG ubiquitin mutant &#8211; NanoBRET assay.  </strong>MCF7 or HEK293T cells were co-transfected with different amounts of N- or C-terminally NL-tagged USP5 and N-terminally HT-tagged Ub or UbdelRGG mutant, as indicated (per 96/well).  The signal was red 48 h post transfection. <strong>A. </strong>Best WT to mutant ratio was observed in MCF7 transfected with 0.02 µg of HT-Ub/UbdelRGG and 0.001 µg of N- terminally NL-tagged USP5. <strong>B, C</strong>. Mean corrected NanoBRET ratio (mBU). The condition with the best WT to mutant ratio (2.1) is marked in red. <strong>NL</strong>-NanoLuc® tag, <strong>HT</strong>&#8211; HaloTag®Fusion tag, <strong>Ub</strong> – ubiquitin. See for details</p>
<p><img loading="lazy" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/03/Data-2-300x130.png" alt="" class="alignnone wp-image-4392" width="792" height="343" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/03/Data-2-300x130.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/03/Data-2-1024x443.png 1024w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/03/Data-2-768x332.png 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/03/Data-2-1536x665.png 1536w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/03/Data-2.png 1864w" sizes="(max-width: 792px) 100vw, 792px" /></p>
<p><strong>Fig.3. USP5 R221A mutation and ubiquitin RGG deletion decrease USP5 and ubiquitin interaction &#8211; NanoBRET assay.  </strong>MCF7 were co-transfected NL- USP5 or USP5 R221A mutant and HT-Ub or UbdelRGG mutant.  The signal was red 48 h post transfection. Experimental triplicates of mean corrected NanoBRET ratios (mBU) normalized to mBU of NL-USP5 and HT-ubiquitin are indicated. <strong>NL</strong>-NanoLuc® tag, <strong>HT</strong>&#8211; HaloTag®Fusion tag, <strong>Ub</strong> – ubiquitin.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/usp5-and-ubiquitin-interaction-assay-nanobret/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>SEC-MALS: USP5 and Ubiquitin</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/sec-mals-usp5-and-ubiquitin/</link>
					<comments>https://thesgc.github.io/static-openlabnotebooks/sec-mals-usp5-and-ubiquitin/#respond</comments>
		
		<dc:creator><![CDATA[Mandeep Mann]]></dc:creator>
		<pubDate>Tue, 24 Mar 2020 17:35:55 +0000</pubDate>
				<category><![CDATA[Mandeep Mann]]></category>
		<category><![CDATA[SGC Univ. of Toronto]]></category>
		<category><![CDATA[USP5]]></category>
		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=4375</guid>

					<description><![CDATA[Hi all! Hope everyone is staying safe and practising social distancing during these difficult times. Working from home, I’ve decided to catch up on my open notebook. In a previous post, I purified various full length USP5 constructs and determined the binding affinity of ubiquitin to these constructs. I wanted to determine the stoichiometry of <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/sec-mals-usp5-and-ubiquitin/">Read More ...</a>]]></description>
										<content:encoded><![CDATA[<p>Hi all! Hope everyone is staying safe and practising social distancing during these difficult times. Working from home, I’ve decided to catch up on my open notebook.</p>
<p>In a previous post, I <a href="https://thesgc.github.io/static-openlabnotebooks/growth-and-purification-of-biotinylated-usp5-constructs-testing-znf-ubd-ligands-in-a-displacement-assay/">purified various full length USP5 constructs</a> and determined the <a href="https://thesgc.github.io/static-openlabnotebooks/do-znf-ubd-ligands-bind-full-length-usp5/">binding affinity of ubiquitin</a> to these constructs. I wanted to determine the stoichiometry of ubiquitin (Ubq) binding to USP5, as USP5 has two ubiquitin-associated domains, in addition to its canonical zinc-finger ubiquitin binding domain (ZnF-UBD) and a cryptic ZnF-UBP domain (Figure 1)<sup>1</sup>.<img loading="lazy" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/03/20200324a-300x174.png" alt="" width="524" height="304" class=" wp-image-4376 aligncenter" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/03/20200324a-300x174.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/03/20200324a-1024x595.png 1024w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/03/20200324a-768x446.png 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/03/20200324a.png 1119w" sizes="(max-width: 524px) 100vw, 524px" /></p>
<p style="text-align: center;"><strong>Figure 1</strong>. Schematic of full-length USP5 (grey) bound to ubiquitin (blue) (PDB: 3IHP): canonical ZnF-UBD (purple), cryptic ZnF-UBP (light blue), ubiquitin-associated domain-1 (yellow), ubiquitin-associated domain-2 (orange)</p>
<p>I used size exclusion chromatography-multiple angle light scattering (SEC-MALS) to determine the molar mass of the full-length USP5 protein in the presence and absence of an excess of monoubiquitin. MALS measures the light scattered by a protein at a range of angles allowing for extrapolation to determine molecular weight using a refractive index (RI) detector. Please see experimental details on <b><a href="https://zenodo.org/record/3726000#.XnpDZIhKjIU">Zenodo</a>. </b></p>
<p>I looked at two full-length USP5 constructs: wildtype (WT) USP5, and an R221A mutant (this is a mutation at the canonical ZnF-UBD) in the presence and absence of ubiquitin (Figure 2 &amp; 3). The molecular weight is summarized in Table 1.</p>
<p><strong>Table 1</strong>. Summary of Peak <a href="https://www.agilent.com/cs/library/technicaloverviews/Public/5990-7890EN.pdf">Molar Mass Moment</a> and Molecular Weight</p>
<table width="444" style="font-size: 1.5rem; width: 100%;">
<tbody>
<tr>
<td width="151" style="width: 33.4545%;"></td>
<td width="161" style="width: 35.5152%;"><strong>Mp (g/mol)</strong></td>
<td width="132" style="width: 29.9394%;"><strong>Peak Molecular Weight (kDa)</strong></td>
</tr>
<tr>
<td width="151" style="width: 33.4545%;"><strong>WT USP5</strong></td>
<td width="161" style="width: 35.5152%;">9.970 x 10<sup>4 </sup>(±0.271%)</td>
<td width="132" style="width: 29.9394%;">99.7</td>
</tr>
<tr>
<td width="151" style="width: 33.4545%;"><strong>WT USP5 + Ubq</strong></td>
<td width="161" style="width: 35.5152%;">1.068 x 10<sup>5 </sup>(±0.338%)</td>
<td width="132" style="width: 29.9394%;">106.8</td>
</tr>
<tr>
<td width="151" style="width: 33.4545%;"><strong>R221A USP5 </strong></td>
<td width="161" style="width: 35.5152%;">1.064 x 10<sup>5</sup> (±0.321%)</td>
<td width="132" style="width: 29.9394%;">106.4</td>
</tr>
<tr>
<td width="151" style="width: 33.4545%;"><strong>R221A USP5 + Ubq</strong></td>
<td width="161" style="width: 35.5152%;">1.059 x 10<sup>5</sup> (±0.351%)</td>
<td width="132" style="width: 29.9394%;">105.9</td>
</tr>
</tbody>
</table>
<p><img loading="lazy" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/03/20200324b-300x117.png" alt="" width="579" height="226" class="wp-image-4377 aligncenter" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/03/20200324b-300x117.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/03/20200324b-1024x400.png 1024w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/03/20200324b-768x300.png 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/03/20200324b.png 1430w" sizes="(max-width: 579px) 100vw, 579px" /></p>
<p style="text-align: center;"><strong>Figure 2</strong>. SEC-MALS of wildtype USP5 only (black) and wildtype USP5 + Ubq (blue)</p>
<p><img loading="lazy" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/03/20200324c-300x123.png" alt="" width="615" height="252" class="wp-image-4378 aligncenter" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/03/20200324c-300x123.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/03/20200324c-1024x418.png 1024w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/03/20200324c-768x314.png 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/03/20200324c.png 1493w" sizes="(max-width: 615px) 100vw, 615px" /></p>
<p style="text-align: center;"><strong>Figure 3</strong>. SEC-MALS of R221A mutant USP5 only (black) and R221A USP5 + Ubq (blue)</p>
<p>WT USP5 is fairly monodispersed (Mw/Mn= 1.1) and has a molecular weight of approximately 99 kDa, similar to the expected molecular weight of the protein which is 95.3 k Da. WT USP5 + Ubq elutes at the same volume as WT USP5 (17.4 mL) and has a molecular weight of approximately 107 kDa. This corresponds to 1:1 binding of ubiquitin (MW= 8.6 kDa) to USP5.</p>
<p>R221A USP5 has an approximate molecular weight of 106 kDa, which is higher than the expected molecular weight of the protein (MW= 99.6 kDa). R221A + Ubq also has an approximate molecular weight of 106 kDa. The mutant R221A ± Ubq are not significantly different and without orthogonal experiments, it is difficult to interpret what the MALS data means. Interestingly, there was a shift in the elution volume of the R221A + Ubq compared to R221A, where the R221A + Ubq elutes approximately 0.2 mL before R221A USP5. Perhaps, there is a conformational shift of the R221A USP5 in the presence of ubiquitin. Large conformational remodeling of full-length USP5 was previously suggested<sup>1</sup>.</p>
<p>Next, we will use dynamic light scattering (DLS) and small angle X-ray scattering (SAXS) to better understand ubiquitin binding to various USP5 constructs, including R221A. Stay tuned!</p>
<p>&nbsp;</p>
<p><sup>1</sup><em>Biochemistry</em> 2012, 51, 6, 1188-1198</p>
]]></content:encoded>
					
					<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/sec-mals-usp5-and-ubiquitin/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Expansion of UBTR012574 Chemical Series</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/expansion-of-ubtr012574-chemical-series/</link>
					<comments>https://thesgc.github.io/static-openlabnotebooks/expansion-of-ubtr012574-chemical-series/#respond</comments>
		
		<dc:creator><![CDATA[Mandeep Mann]]></dc:creator>
		<pubDate>Mon, 09 Mar 2020 15:10:58 +0000</pubDate>
				<category><![CDATA[Mandeep Mann]]></category>
		<category><![CDATA[SGC Univ. of Toronto]]></category>
		<category><![CDATA[USP5]]></category>
		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=4351</guid>

					<description><![CDATA[In a previous post, we solved the co-crystal structure of the USP5 zinc finger ubiquitin-binding domain (ZnF-UBD) with a promising compound, UBTR012574, which had a potency of approximately 10 µM (Figure 1). W expanded the chemical series of UBTR012574 by docking analogue compounds from the Enamine REAL database and Scifinder. We decided to order 17 <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/expansion-of-ubtr012574-chemical-series/">Read More ...</a>]]></description>
										<content:encoded><![CDATA[<p>In a previous post, we <a href="https://thesgc.github.io/static-openlabnotebooks/usp5-znf-ubd-co-crystal-structure-with-compound-ubtr012574a/">solved the co-crystal structure of the USP5 zinc finger ubiquitin-binding domain</a> (ZnF-UBD) with a promising compound, UBTR012574, which had a <a href="https://thesgc.github.io/static-openlabnotebooks/testing-usp5-znf-ubd-analogues-with-a-displacement-assay-and-spr/">potency of approximately 10 µM</a> (Figure 1). W expanded the chemical series of UBTR012574 by docking analogue compounds from the Enamine REAL database and Scifinder. We decided to order 17 of these compounds based on the docking poses and assessed the binding potency using a surface plasmon resonance (SPR) assay. You can find details of the experiment on <strong><a href="https://zenodo.org/record/3701505#.XmZapahKjIU">Zenodo</a>.</strong></p>
<p><img loading="lazy" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/03/20200309a-300x101.png" alt="" width="434" height="146" class="wp-image-4352 aligncenter" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/03/20200309a-300x101.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/03/20200309a.png 705w" sizes="(max-width: 434px) 100vw, 434px" /></p>
<p style="text-align: center;"><strong>Figure 1</strong>. UBTR012574</p>
<p>Of the analogues tested, UBTR020994a and UBTR020989a had a similar potency as UBTR012574 for USP5 ZnF-UBD. These compounds also bind to HDAC6 ZnF-UBD with similar potency. Compound UBTR020988a, which has a nitrogen atom in the carboxylic chain results in weaker potency (~40 µM) than UBTR012574 for USP5 ZnF-UBD but is <strong>6-fold</strong> selective for USP5 over HDAC6 (Figure 2). We are working with chemists to expand the chemical series further with the nitrogen group in the carboxylic chain- we hope to improve potency and retain selectivity for USP5 ZnF-UBD. Stay tuned!</p>
<p><img loading="lazy" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/03/20200309b-300x227.png" alt="" width="459" height="347" class="wp-image-4353 aligncenter" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/03/20200309b-300x227.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/03/20200309b-250x188.png 250w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/03/20200309b.png 707w" sizes="(max-width: 459px) 100vw, 459px" /></p>
<p style="text-align: center;"><strong>Figure 2</strong>. UBTR012574 chemical series a) UBTR012574 b) UBTR020994a c) UBTR020989a d) UBTR20988a</p>
<p>&nbsp;</p>
<table data-upload-id="file_upload:10c39f77-14be-42ff-ab3f-0249931ac40b">
<thead>
<tr>
<th>Structure Image</th>
<th>Smiles</th>
<th>Mol. Weight</th>
</tr>
</thead>
<tbody>
<tr>
<td><img src="data:image/png;base64,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" /></td>
<td>O=C(O)CCC(=O)c1ccc(S(=O)(=O)N2CCCC(C(F)(F)F)C2)cc1</td>
<td>393.4</td>
</tr>
<tr>
<td><img src="data:image/png;base64,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" /></td>
<td>O=C(O)CCC(=O)c1ccc(S(=O)(=O)N2CCC3(CCO3)CC2)cc1</td>
<td>367.4</td>
</tr>
<tr>
<td><img src="data:image/png;base64,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" /></td>
<td>O=C(O)CCC(=O)c1ccc(S(=O)(=O)N2CCC(c3ccc(F)c(F)c3)CC2)cc1</td>
<td>437.5</td>
</tr>
<tr>
<td><img src="data:image/png;base64,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" /></td>
<td>O=C(O)CCC(=O)c1ccc(S(=O)(=O)N2CCSCC2)cc1</td>
<td>343.4</td>
</tr>
<tr>
<td><img src="data:image/png;base64,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" /></td>
<td>O=C(O)CNC(=O)c1ccc(S(=O)(=O)N2CCC(c3ccc(F)c(F)c3)CC2)cc1</td>
<td>438.5</td>
</tr>
</tbody>
</table>
<p><a href="/wp-content/uploads/2020/03/4351_e7fde1c8-56db-446b-9e2c-e2e1541268b0.sdf">Download SDF file</a></p>
]]></content:encoded>
					
					<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/expansion-of-ubtr012574-chemical-series/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>USP5 ZnF-UBD Co-Crystal Structure with Compound UBTR012574a</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/usp5-znf-ubd-co-crystal-structure-with-compound-ubtr012574a/</link>
					<comments>https://thesgc.github.io/static-openlabnotebooks/usp5-znf-ubd-co-crystal-structure-with-compound-ubtr012574a/#respond</comments>
		
		<dc:creator><![CDATA[Mandeep Mann]]></dc:creator>
		<pubDate>Tue, 21 Jan 2020 18:59:45 +0000</pubDate>
				<category><![CDATA[Mandeep Mann]]></category>
		<category><![CDATA[SGC Univ. of Toronto]]></category>
		<category><![CDATA[USP5]]></category>
		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=4160</guid>

					<description><![CDATA[A Happy New Year to all! I am back from vacation and ready to jump back into my work with USP5. Great news- we solved the co-crystal structure of USP5 with a promising compound, UBTR012574a (Figure 1) (discussed in my last post), just before the Christmas holidays. You can check out details about co-crystal growth, <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/usp5-znf-ubd-co-crystal-structure-with-compound-ubtr012574a/">Read More ...</a>]]></description>
										<content:encoded><![CDATA[<p>A Happy New Year to all! I am back from vacation and ready to jump back into my work with USP5.</p>
<p>Great news- we solved the co-crystal structure of USP5 with a promising compound, UBTR012574a (Figure 1) (discussed in my <a href="https://thesgc.github.io/static-openlabnotebooks/testing-usp5-znf-ubd-analogues-with-a-displacement-assay-and-spr/">last post</a>), just before the Christmas holidays. You can check out details about co-crystal growth, and how the structure was solved on <strong><a href="https://zenodo.org/record/3620775#.XidImchKjIU">Zenodo</a>. </strong></p>
<p style="text-align: center;"><img loading="lazy" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/01/Figure1-300x100.png" alt="" width="300" height="100" class="size-medium wp-image-4161 aligncenter" style="font-size: 1.5rem;" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/01/Figure1-300x100.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/01/Figure1.png 359w" sizes="(max-width: 300px) 100vw, 300px" /><strong>Figure 1</strong>. com<span style="font-size: 1.5rem;">pound UBTR012574a</span></p>
<p>I crystallized the complex of USP5 ZnF-UBD with UBTR012574a, and the structure was solved by Dr. Aiping Dong to a resolution of 1.98 Å. This compound was originally selected by <a href="https://thesgc.github.io/static-openlabnotebooks/prioritizing-commercial-analogues-of-previous-usp5-znf-ubd-hits/">virtual screening</a>. The experimental binding pose turned out to very similar to the predicted/docked one, except for the difluoro phenyl group, which is flipped out of the pocket compared to the predicted docked pose (Figure 2).</p>
<p><img loading="lazy" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/01/Figure2-300x214.png" alt="" width="300" height="214" class="size-medium wp-image-4162 aligncenter" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/01/Figure2-300x214.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/01/Figure2.png 496w" sizes="(max-width: 300px) 100vw, 300px" /></p>
<p style="text-align: center;"><strong>Figure 2</strong>. Ribbon diagram of USP5 ZnF-UBD (grey) with UBTR012574; predicted docked pose (cyan) and experimental pose (orange)</p>
<p>The addition of the extended sulfonamide moiety, outlined in red in Figure 3, increased potency 60-fold from the parent compound (outlined in green in Figure 3). There are some pi-interactions with Y223 in the binding pocket that could explain this increase in potency. The good news is there are several areas of improvement in this compound based on the co-crystal structure. Potential improvements may be to replace the piperidine with an aromatic ring to improve pi-interactions with Y223. Decorating the outer phenyl ring with polar groups may lend to hydrogen bond interactions with D225.</p>
<p><img loading="lazy" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/01/Figure3-300x216.png" alt="" width="300" height="216" class="size-medium wp-image-4163 aligncenter" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/01/Figure3-300x216.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2020/01/Figure3.png 602w" sizes="(max-width: 300px) 100vw, 300px" /></p>
<p style="text-align: center;"><strong>Figure 3</strong>. Co-crystal structure of USP5 ZnF-UBD and UBTR012574a</p>
<p>Next, I’ll be looking for commercial analogues of UBTR012574a to get a better understanding of the structure activity relationship of the extended sulfonamide group at the para position of the benzene ring. We also are hoping to have some chemistry resources soon, so I’ll be designing some analogues of interest based on the co-crystal structure of USP5 ZnF-UBD and UBTR012574a.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/usp5-znf-ubd-co-crystal-structure-with-compound-ubtr012574a/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Testing USP5 ZnF-UBD analogues with a Displacement Assay and SPR</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/testing-usp5-znf-ubd-analogues-with-a-displacement-assay-and-spr/</link>
					<comments>https://thesgc.github.io/static-openlabnotebooks/testing-usp5-znf-ubd-analogues-with-a-displacement-assay-and-spr/#respond</comments>
		
		<dc:creator><![CDATA[Mandeep Mann]]></dc:creator>
		<pubDate>Fri, 15 Nov 2019 16:49:40 +0000</pubDate>
				<category><![CDATA[Mandeep Mann]]></category>
		<category><![CDATA[SGC Univ. of Toronto]]></category>
		<category><![CDATA[USP5]]></category>
		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=3784</guid>

					<description><![CDATA[If you’ve been following along my open notebook journey over the last two years, you’ll be excited to hear I’ve published my work on the first antagonists of USP5 ZnF-UBD in a peer-reviewed journal. Check it out here! In a previous post, I outlined my selection of the next set of analogues in my chemical <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/testing-usp5-znf-ubd-analogues-with-a-displacement-assay-and-spr/">Read More ...</a>]]></description>
										<content:encoded><![CDATA[<p>If you’ve been following along my open notebook journey over the last two years, you’ll be excited to hear I’ve published my work on the first antagonists of USP5 ZnF-UBD in a peer-reviewed journal. Check it out <a href="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b00988">here</a>!</p>
<p>In a <a href="https://thesgc.github.io/static-openlabnotebooks/prioritizing-commercial-analogues-of-previous-usp5-znf-ubd-hits/">previous post</a>, I outlined my selection of the next set of analogues in my chemical series against USP5 ZnF-UBD to continue to understand the structure activity relationship and to improve potency. I used a <a href="https://thesgc.github.io/static-openlabnotebooks/growth-and-purification-of-biotinylated-usp5-constructs-testing-znf-ubd-ligands-in-a-displacement-assay/">displacement assay</a>, which I described a few weeks ago to screen 20 commercial compounds that I had selected by <a href="https://thesgc.github.io/static-openlabnotebooks/prioritizing-commercial-analogues-of-previous-usp5-znf-ubd-hits/">virtual screening</a>. The best displacing compounds were then tested using a surface plasmon resonance (SPR) assay. You can see details on <a href="https://zenodo.org/record/3543630#.Xc7VHFdKjIU"><strong>Zenodo</strong></a>.</p>
<p>The displacement assay results are summarized in Figure 1. Compound displacement comparable to the control compound 21, a compound that has a K<sub>D</sub> of approximately 60 µM, were selected to be tested by SPR to determine binding affinities.</p>
<p><img loading="lazy" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/11/20191115a-300x138.png" alt="" width="504" height="232" class="wp-image-3785 aligncenter" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/11/20191115a-300x138.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/11/20191115a-768x354.png 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/11/20191115a.png 824w" sizes="(max-width: 504px) 100vw, 504px" /></p>
<p style="text-align: center;"><strong>Figure 1</strong>. Summary of displacement screen</p>
<p>One of the most promising compounds, UBTR012574a has a K<sub>D</sub> of approximately 10 µM, a significant increase in potency from the parent molecules (Figure 2).</p>
<p><img loading="lazy" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/11/20191115b-300x78.png" alt="" width="554" height="144" class="wp-image-3786 aligncenter" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/11/20191115b-300x78.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/11/20191115b-768x200.png 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/11/20191115b.png 930w" sizes="(max-width: 554px) 100vw, 554px" /></p>
<p style="text-align: center;"><strong>Figure 2</strong>. SAR of chemical series</p>
<p>In the next couple of weeks, I will try to solve the co-crystal structure of USP5 ZnF-UBD in complex with UBTR012574a to determine if the predicted binding pose is similar to the experimental binding pose. This will give us some insight into what chemical moieties of the compound are lending to the increased potency. I am also going back to Enamine’s REAL database and looking for compounds similar to UBTR012574a. I’ll be ordering some more analogues to get a better understanding of the structure activity relationship of the extended sulfonamide groups at the para position of the benzene ring. Stay tuned!</p>
<table data-upload-id="file_upload:c78ea65a-c105-4828-83d8-8a810d540c79">
<thead>
<tr>
<th>Structure Image</th>
<th>Smiles</th>
<th>Mol. Weight</th>
</tr>
</thead>
<tbody>
<tr>
<td><img src="data:image/png;base64,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" /></td>
<td>Cc1sc2ncn(CC(=O)[O-])c(=O)c2c1C</td>
<td>237.3</td>
</tr>
<tr>
<td><img src="data:image/png;base64,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" /></td>
<td>CC(=O)N1CCN(C(=O)CCC(=O)[O-])CC1</td>
<td>227.2</td>
</tr>
<tr>
<td><img src="data:image/png;base64,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" /></td>
<td>O=C(O)Cn1ccc2ccccc2c1=O</td>
<td>203.2</td>
</tr>
<tr>
<td><img src="data:image/png;base64,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" /></td>
<td>CSc1nc(C)c(CCC(=O)[O-])c(=O)[nH]1</td>
<td>227.3</td>
</tr>
<tr>
<td><img src="data:image/png;base64,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" /></td>
<td>O=C(O)CN1Cc2ccccc2C1=O</td>
<td>191.2</td>
</tr>
</tbody>
</table>
<p><a href="/wp-content/uploads/2019/11/3784_2fafe62b-d22f-43da-888c-d2e7376644ae.sdf">Download SDF file</a></p>
]]></content:encoded>
					
					<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/testing-usp5-znf-ubd-analogues-with-a-displacement-assay-and-spr/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>USP5 Ubiquitin-Rhodamine110 Catalytic Activity Assay</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/usp5-ubiquitin-rhodamine110-catalytic-activity-assay/</link>
					<comments>https://thesgc.github.io/static-openlabnotebooks/usp5-ubiquitin-rhodamine110-catalytic-activity-assay/#respond</comments>
		
		<dc:creator><![CDATA[Mandeep Mann]]></dc:creator>
		<pubDate>Thu, 24 Oct 2019 13:05:06 +0000</pubDate>
				<category><![CDATA[Mandeep Mann]]></category>
		<category><![CDATA[SGC Univ. of Toronto]]></category>
		<category><![CDATA[USP5]]></category>
		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=3725</guid>

					<description><![CDATA[Today’s post describes testing if ZnF-UBD ligands are able to antagonize USP5 catalytic activity using a ubiquitin-rhodamine110 (UbRho110) assay, which was developed and optimized by Leanna Smith of the Biophysics group at SGC Toronto. You can see details on Zenodo.  The UbRho110 assay is a fluorescence intensity assay that monitors the enzymatic activity of deubiquitinating <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/usp5-ubiquitin-rhodamine110-catalytic-activity-assay/">Read More ...</a>]]></description>
										<content:encoded><![CDATA[<p>Today’s post describes testing if ZnF-UBD ligands are able to antagonize USP5 catalytic activity using a ubiquitin-rhodamine110 (UbRho110) assay, which was developed and optimized by Leanna Smith of the Biophysics group at SGC Toronto. You can see details on <strong><a href="https://zenodo.org/record/3518149#.XbGgUUZKjIU">Zenodo</a>. </strong></p>
<p>The UbRho110 assay is a fluorescence intensity assay that monitors the enzymatic activity of deubiquitinating proteases using a fluorogenic rhodamine-based substrate<sup>1</sup>. Cleavage of UbRho110 by a deubiquitinase (DUB) enzyme results in monosubstituted rhodamine which exhibits fluorescence when excited at 485 nm<sup>1</sup> (Figure 1).</p>
<p><img loading="lazy" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/10/20191024b-300x42.png" alt="" class="wp-image-3726 aligncenter" width="436" height="61" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/10/20191024b-300x42.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/10/20191024b.png 506w" sizes="(max-width: 436px) 100vw, 436px" /></p>
<p style="text-align: center;"><strong>Figure 1</strong>. UbRho110 Assay</p>
<p>Introduction of a ZnF-UBD mutant, R221A, <a href="https://zenodo.org/record/3403804#.XbBu7EZKjIV">described in previous posts</a>, results in approximately 40% DUB activity compared to the WT USP5 (Figure 2). This result is consistent with previous reports which suggest binding of ubiquitin to the ZnF-UBD allosterically activates USP5 catalytic activity<sup>2,3</sup>. USP5 is a cysteine protease, and cleaves polyubiquitin chains at the site of isopeptide bonds between the C-terminal glycine of one ubiquitin and a terminal nitrogen group of the adjacent ubiquitin. Mutation of the catalytic cysteine (C) to an alanine (A) [C335A] results in no USP5 DUB activity, as expected.</p>
<p><img loading="lazy" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/10/20191024c-e1571922191599-300x188.png" alt="" class="wp-image-3727 size-medium aligncenter" width="300" height="188" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/10/20191024c-e1571922191599-300x188.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/10/20191024c-e1571922191599.png 443w" sizes="(max-width: 300px) 100vw, 300px" /></p>
<p style="text-align: center;"><strong>Figure 2</strong>. DUB activity of USP5 constructs (n=2)</p>
<p>To determine if ZnF-UBD ligands antagonize USP5 activity in the UbRho110 assay, I tested one of our most promising ligands, XST00090960c using optimized assay conditions. XST00090960c inhibits approximately 75% of USP5 activity at the maximum concentration tested (Figure 3). Therefore, ZnF-UBD ligands are able to antagonize USP5 catalytic cleavage of the UbRho110 substrate. It should be noted, UbRho110 is not a native substrate, and further validation with native polyubiquitin species in an orthogonal assay is required. In the future I plan to use a western blot assay to determine whether ZnF-UBD ligands antagonize native polyubiquitin species.</p>
<p>&nbsp;</p>
<p><img loading="lazy" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/10/20191024d-300x107.png" alt="" class="wp-image-3728 aligncenter" width="600" height="214" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/10/20191024d-300x107.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/10/20191024d-768x273.png 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/10/20191024d-1024x364.png 1024w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/10/20191024d.png 1468w" sizes="(max-width: 600px) 100vw, 600px" /></p>
<p style="text-align: center;"><strong>Figure 3</strong>. Representative activity data of compound XST00090960c</p>
<p><u>References</u></p>
<p><sup>1</sup>Hassiepen, U.; Eidhoff, U.; Meder, G.; Bulber, J. F.; Hein, A.; Bodendorf, U.; Lorthiois, E.; Martoglio, B. A Sensitive Fluorescence Intensity Assay for Deubiquitinating Proteases Using Ubiquitin-Rhodamine110-Glycine as Substrate. <em>Anal. Biochem.</em> <strong>2007</strong>, 371, 201-207.</p>
<p><sup>2</sup>Reyes-Turcu, F. E.; Horton, J. R.; Mullally, J. E.; Heroux, A.; Cheng, X.; Wilkinson, K. D. The Ubiquitin Binding Domain ZnF UBP Recognizes the C-Terminal Diglycine Motif of Unanchored Ubiquitin. <em>Cell</em> <strong>2006</strong>, 124, 1197-1208.</p>
<p><sup>3</sup>Avvakumov, G. V.; Walker, J. R.; Xue, S.; Allali-Hassani, A.; Asinas, A.; Nair, U. B.; Fang, X.; Zuo, X.; Wang, Y. X.; Wilkinson, K. D.; Dhe-Paganon, S. Two ZnF-UBP Domains in Isopeptidase T (USP5). <em>Biochemistry</em> <strong>2012</strong>, 51, 1188-1198.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/usp5-ubiquitin-rhodamine110-catalytic-activity-assay/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Do ZnF-UBD ligands bind full length USP5?</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/do-znf-ubd-ligands-bind-full-length-usp5/</link>
					<comments>https://thesgc.github.io/static-openlabnotebooks/do-znf-ubd-ligands-bind-full-length-usp5/#respond</comments>
		
		<dc:creator><![CDATA[Mandeep Mann]]></dc:creator>
		<pubDate>Thu, 24 Oct 2019 12:47:00 +0000</pubDate>
				<category><![CDATA[Mandeep Mann]]></category>
		<category><![CDATA[SGC Univ. of Toronto]]></category>
		<category><![CDATA[USP5]]></category>
		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=3722</guid>

					<description><![CDATA[In a previous post, I described the expression and purification of full length (FL) USP5 constructs and also determined that zinc finger ubiquitin-binding (ZnF-UBD) ligands are able to displace ubiquitin in both the ZnF-UBD and the FL protein in a fluorescence displacement assay. In today’s post, I describe using a surface plasmon resonance (SPR) assay <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/do-znf-ubd-ligands-bind-full-length-usp5/">Read More ...</a>]]></description>
										<content:encoded><![CDATA[<p>In a <a href="https://thesgc.github.io/static-openlabnotebooks/growth-and-purification-of-biotinylated-usp5-constructs-testing-znf-ubd-ligands-in-a-displacement-assay/">previous post</a>, I described the expression and purification of full length (FL) USP5 constructs and also determined that zinc finger ubiquitin-binding (ZnF-UBD) ligands are able to displace ubiquitin in both the ZnF-UBD and the FL protein in a fluorescence displacement assay.</p>
<p>In today’s post, I describe using a surface plasmon resonance (SPR) assay to determine if the ZnF-UBD ligands bind to FL USP5. You can see details of these experiments on <strong><a href="https://zenodo.org/record/3518127#.XbGcPUZKjIU">Zenodo</a></strong>.</p>
<p>I tested ligands against 4 protein constructs:</p>
<ol>
<li>ZnF-UBD wild-type (WT)</li>
<li>ZnF-UBD R221A</li>
<li>FL USP5 WT</li>
<li>FL USP5 R221A</li>
</ol>
<p>If you’ll recall, R221 is an important residue in the binding pocket of the ZnF-UBD and is involved in ligand co-ordination. A mutation of the arginine (R) to alanine (A) should prevent binding of ubiquitin and the inhibitors to the ZnF-UBD.</p>
<p>Ligand binding to the WT ZnF-UBD and the FL protein are comparable. For example, in this experiment, compound XST00090960c binds to the ZnF-UBD with a K<sub>D</sub> of 58 ± 1 µM and to FL USP5 with a KD of 84 ± 37 µM (Table 1). There was no binding of XST00090960c to the ZnF-UBD R221A and FL USP5 R221A confirming that the ligand is indeed binding to the ZnF-UBD in the context of the FL protein. These results corroborate <a href="https://zenodo.org/record/3403804#.XbBXNUZKjIV">previous displacement assay</a> findings.</p>
<p>Interestingly, ubiquitin binds to FL USP5 R221A (K<sub>D</sub>=38 ± 3 µM) 100-fold weaker than the FL USP5 WT (K<sub>D</sub>=0.3 ± 0.1 µM). This is because the FL USP5 contains multiple ubiquitin associated domains that are still able to bind ubiquitin; however the decrease in ubiquitin binding with a R221A mutation shows that the ZnF-UBD is an important domain in co-ordinating ubiquitin binding to the FL protein.</p>
<p><strong>Table 1</strong>. SPR data of ZnF-UBD ligands</p>
<p><img loading="lazy" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/10/20191024a-300x105.png" alt="" class="alignnone wp-image-3723" width="620" height="217" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/10/20191024a-300x105.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/10/20191024a-768x269.png 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/10/20191024a.png 1024w" sizes="(max-width: 620px) 100vw, 620px" /></p>
]]></content:encoded>
					
					<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/do-znf-ubd-ligands-bind-full-length-usp5/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Growth and Purification of Biotinylated USP5 Constructs &#038; Testing ZnF-UBD Ligands in a Displacement Assay</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/growth-and-purification-of-biotinylated-usp5-constructs-testing-znf-ubd-ligands-in-a-displacement-assay/</link>
					<comments>https://thesgc.github.io/static-openlabnotebooks/growth-and-purification-of-biotinylated-usp5-constructs-testing-znf-ubd-ligands-in-a-displacement-assay/#respond</comments>
		
		<dc:creator><![CDATA[Mandeep Mann]]></dc:creator>
		<pubDate>Tue, 10 Sep 2019 12:54:56 +0000</pubDate>
				<category><![CDATA[Mandeep Mann]]></category>
		<category><![CDATA[SGC Univ. of Toronto]]></category>
		<category><![CDATA[USP5]]></category>
		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=3462</guid>

					<description><![CDATA[Hi all, today’s post covers some concepts that I have previously described: expression and purification of protein constructs, and testing ligands in a displacement assay. If you’ll recall, I tried to develop and optimize a fluorescence polarization (FP) displacement assay for the ZnF-UBD of USP5 for some time but found that FP was a no <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/growth-and-purification-of-biotinylated-usp5-constructs-testing-znf-ubd-ligands-in-a-displacement-assay/">Read More ...</a>]]></description>
										<content:encoded><![CDATA[<p>Hi all, today’s post covers some concepts that I have previously described: expression and purification of protein constructs, and testing ligands in a displacement assay.</p>
<p>If you’ll recall, I tried to develop and optimize a <a href="https://thesgc.github.io/static-openlabnotebooks/usp5-zf-ubd-fluorescence-polarization-displacement-assay-3/">fluorescence polarization (FP) displacement assay</a> for the ZnF-UBD of USP5 for some time but found that FP was a no go to screen libraries due to a low dynamic range. For the past couple of weeks, I’ve been working on purifying biotinylated USP5 protein constructs (full-length and ZnF-UBD) to use them in a different displacement assay. You can see details of these experiments on <a href="https://zenodo.org/record/3403804#.XXeaaihKjIU"><strong>Zenodo</strong></a>.</p>
<p>I was successful in purifying various USP5 constructs with a biotin tag. I expressed and purified the constructs summarized in <strong>Table 1</strong>. Constructs 1-835 are the full length protein, while constructs 171-290 are the ZnF-UBD that I have previously crystallized in complex with my screening hits. R221A mutants were used as controls for the displacement assay. R221 is an important residue in the binding pocket of the ZnF-UBD that co-ordinates ubiquitin binding. A mutation of the arginine (R) to an alanine (A) should prevent binding of ubiquitin (and of my inhibitors) to the ZnF-UBD<sup>1,2</sup>. C335A is a mutation of the catalytic cysteine residue that carries out the cleavage of polyubiquitin chains<sup>3</sup>.</p>
<p style="text-align: center;"><strong>Table 1</strong>. USP5 construct Summary</p>
<p><img loading="lazy" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/20190910a-300x137.png" alt="" class="wp-image-3463 aligncenter" width="579" height="264" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/20190910a-300x137.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/20190910a-768x351.png 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/20190910a.png 872w" sizes="(max-width: 579px) 100vw, 579px" /></p>
<p>The workflow of the displacement assay is summarized in<strong> Figure 1</strong>. A biotinylated protein is captured to a streptavidin coated plate. Excess protein is removed through washes and a fluorescently labeled ubiquitin (FITC-UBQ) is displaced by a competing ligand resulting in a decrease in fluorescence after wash steps to remove unbound ligands.</p>
<p><img loading="lazy" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/20190910b-300x121.png" alt="" class="wp-image-3464 aligncenter" width="746" height="301" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/20190910b-300x121.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/20190910b-768x309.png 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/20190910b.png 1618w" sizes="(max-width: 746px) 100vw, 746px" /></p>
<p style="text-align: center;"><strong>Figure 1</strong>. Workflow of Displacement Assay</p>
<p>&nbsp;</p>
<p>I tested two ligands) in the displacement assay: unlabelled UBQ, and cpd 21 (<strong>Figure 2</strong>).</p>
<p><img loading="lazy" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/20190910c-300x175.png" alt="" class="size-medium wp-image-3465 aligncenter" width="300" height="175" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/20190910c-300x175.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/20190910c.png 342w" sizes="(max-width: 300px) 100vw, 300px" /></p>
<p style="text-align: center;"><strong>Figure 2</strong>. Compound structure of cpd 21</p>
<p>Both UBQ and cpd 21 displaced FITC-UBQ from the ZnF-UBD from FL USP5 (<strong>Figure 3</strong>). A mutation of the R221 residue to an alanine resulted in no capture of FITC-UBQ and thus no displacement for UBQ and cpd 21 for both the ZnF-UBD and FL USP5.</p>
<p><img loading="lazy" src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/20190910f-168x300.png" alt="" class="wp-image-3474 aligncenter" width="458" height="818" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/20190910f-168x300.png 168w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/20190910f-574x1024.png 574w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/20190910f.png 674w" sizes="(max-width: 458px) 100vw, 458px" /></p>
<p style="text-align: center;"><strong>Figure 3. </strong>Displacement Assay summary of a) USP5 ZnF-UBD: TOC011B06 (WT-wild type) and TOC023B06 (R221A) and b) FL USP5: TOC023A01 (WT) and TOC023A06 (R221A). HS= hill slope, NC= not calculated.</p>
<p>It should be noted these are preliminary results, and the displacement curves are still quite noisy. Sources of error could include variation of the levels of streptavidin in each well of the 384-Greiner plate. For example, there may be more protein and FITC-UBQ captured in one well over another. This is why it will be important to repeat the experiment several times before having confidence in the reported Kdisp values.</p>
<p>Nonetheless, this is an important finding for the USP5 project. ZnF-UBD ligands are able to displace ubiquitin in both the ZnF-UBD and in the full length protein. Next, I’ll be repeating the experiment several more times to tighten up the data.</p>
<p>References</p>
<p>(1)         Reyes-Turcu, F. E.; Ventii, K. H.; Wilkinson, K. D. Regulation and Cellular Roles of Ubiquitin-Specific Deubiquitinating Enzymes. <em>Annu. Rev. Biochem.</em> <strong>2009</strong>. https://doi.org/10.1146/annurev.biochem.78.082307.091526.</p>
<p>(2)         Reyes-Turcu, F. E.; Horton, J. R.; Mullally, J. E.; Heroux, A.; Cheng, X.; Wilkinson, K. D. The Ubiquitin Binding Domain ZnF UBP Recognizes the C-Terminal Diglycine Motif of Unanchored Ubiquitin. <em>Cell</em> <strong>2006</strong>. https://doi.org/10.1016/j.cell.2006.02.038.</p>
<p>(3)         Scott, D.; Layfield, R.; Oldham, N. J. Structural Insights into Interactions between Ubiquitin Specific Protease 5 and Its Polyubiquitin Substrates by Mass Spectrometry and Ion Mobility Spectrometry. <em>Protein Sci.</em> <strong>2015</strong>. https://doi.org/10.1002/pro.2692.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/growth-and-purification-of-biotinylated-usp5-constructs-testing-znf-ubd-ligands-in-a-displacement-assay/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
